Company News
-
July 16, 2020
Launch of BIOFIRE® MYCOPLASMA
bioMérieux announces the launch of BIOFIRE® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics (antibodies, hormones, cell and gene therapies, etc.), the most vibrant sector in the pharmaceutical industry.
-
May 22, 2020
bioMérieux Receives FDA Clearance to Extend Platelet Shelf Life to 7 Days
bioMérieux announces that its BACT/ALERT® BPA and BPN culture bottles have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Large Volume Delayed Sampling (LVDS) of leukocyte-reduced apheresis platelets (LRAP) and leukocyte-reduced whole blood platelet concentrates (LRWBPC) with BACT/ALERT® 3D and BACT/ALERT® VIRTUO® systems.
Follow us on Socials for more news!
